Effects of tDCS on Social Cognition in Aging (SoCoStim)

June 1, 2022 updated by: University Medicine Greifswald

Effects of tDCS on Visual Perspective Taking and Emotion Recognition in Healthy Older Adults

The aim of the study is to explore the effect of transcranial direct current stimulation (tDCS) on either the right tempo-parietal junction (rTPJ) or the dorsomedial prefrontal cortex (dmPFC) in healthy older adults (replication in a different sample of a study by Martin et al., 2020).

Study Overview

Status

Completed

Conditions

Detailed Description

Humans are fundamentally social animals. The ability to operate within large social networks requires considerable cognitive capacity, often referred to as social cognition. One social cognitive process thought to involve embodied and nonembodied processes is perspective-taking. Recently, the right temporoparietal junction (rTPJ) has been suggested as a key hub for embodied processing relevant to social cognition. A study of Martin et al. (2020) could further provide causal evidence that the right temporoparietal junction is involved specifically in the embodied component of perspective-taking. Specifically, HD-tDCS (high-definition transcranial direct current stimulation) to the right temporoparietal junction, but not another hub of the social brain (dorsomedial PFC), increased the effect of body position during perspective-taking, but not tracking. As social cognition is affected by the aging process and decline of socio-cognitive abilities is a key feature of neurological diseases such as Alzheimer's or Parkinson's disease, the aim of the present study is to replicate the findings of Martin et al., (2020) in a sample of healthy older adults to better understand the modulation of socio-cognitive processes in older age.

The aim of the study is to explore the effect of transcranial direct current stimulation (tDCS) on either the right tempo-parietal junction (rTPJ) or the dorsomedial prefrontal cortex (dmPFC) in healthy older adults (replication in a different sample of a study by Martin et al., 2020). 60 healthy older adults and 30 younger participants (serving as a control group) will be tested in a Reading the Eyes in the Mind Task (RMET) and a Task of Visual Perspective Taking (VPT) , while stimulation either the rTPJ or the dmPFC with either active or sham tDCS (stimulation only in the group of older participants). In the RMET the expectation is that older participants have higher reaction times after correct answers under rTPJ tDCS. No stimulation effects of the dmPFC are expected. In the VPT older participants are expected to have a selective effect on body position (similar to the results of Martin et al., 2020) under rTPJ stimulation, but not dmPFC stimulation.

A further focus of the study is how functional and structural connectivity of the brain and individual differences measured with an MRI assessment influence with the success of the RMET and VPT paradigms in an explorative research question.

Study Type

Interventional

Enrollment (Actual)

90

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Greifswald, Germany, 17489
        • University Medicine Greifswald

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 80 years (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • healthy older (60 - 80 years) and younger (18 - 30 years) participants
  • German as their main language or sufficient german skills to understand the experiment and the task

Exclusion Criteria:

  • participants with neuropsychological or psychiatric disease that affect cognition.
  • standard MRI exclusion criteria (e.g. pregnancy, metal implants)
  • standard tDCS exclusion criteria (e.g. metal implants in the head)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Basic Science
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: Triple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: dmPFC tDCS + Social Cognition tasks in older participants
Participants will receive either active or sham stimulation over the dmPFC while conducting two different social cognition paradigms: one regarding emotion recognition, one on visual perspective taking.
Two paradigms will be tested: visual perspective taking and reading the mind in the eyes.
tDCS either over the dmPFC or the rTPJ.
Experimental: rTPJ tDCS + Social Cognition tasks in older participants
Participants will receive either active or sham stimulation over the rTPJ while conducting two different social cognition paradigms: one regarding emotion recognition, one on visual perspective taking.
Two paradigms will be tested: visual perspective taking and reading the mind in the eyes.
tDCS either over the dmPFC or the rTPJ.
Active Comparator: Social cognition tasks in younger participants
Participants will conduct two different social cognition paradigms: one regarding emotion recognition, one on visual perspective taking but without tDCS stimulation.
Two paradigms will be tested: visual perspective taking and reading the mind in the eyes.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Response Time in milliseconds in Visual-Perspective Taking Paradigm (VPT) in the active tDCS.
Time Frame: at Day 1 or 7 (depends on randomization)
The outcome in the VPT paradigm will be response time in milliseconds (for correct answers only).
at Day 1 or 7 (depends on randomization)
Response Time in milliseconds in Visual-Perspective Taking Paradigm (VPT) in the sham tDCS.
Time Frame: at Day 1 or 7 (depends on randomization)
The outcome in the VPT paradigm will be response time in milliseconds (for correct answers only).
at Day 1 or 7 (depends on randomization)
Response Time in milliseconds in the Reading the mind in the eyes test (RMET) in the active tDCS.
Time Frame: at Day 1 or 7 (depends on randomization)
Outcome in the RMET will be reaction times in milliseconds (of correct answers only) in either rTPJ or dmPFC stimulation in comparison to sham stimulation.
at Day 1 or 7 (depends on randomization)
Response Time in milliseconds in the Reading the mind in the eyes test (RMET) in the sham tDCS.
Time Frame: at Day 1 or 7 (depends on randomization)
Outcome in the RMET will be reaction times in milliseconds (of correct answers only) in either rTPJ or dmPFC stimulation in comparison to sham stimulation.
at Day 1 or 7 (depends on randomization)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Functional and structural connectivity (via MRI)
Time Frame: MRI Assessment takes places before participants are stimulated with tDCS at Baseline (Day 1).
It will be investigated how functional and structural connectivity of the brain and individual differences measured with an MRI assessment influence with the success of the RMET and VPT paradigms in an explorative research question.Structural and functional connectivity will be assessed.
MRI Assessment takes places before participants are stimulated with tDCS at Baseline (Day 1).

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Marcus Meinzer, Dr., Universitymedicine Greifswald

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

August 1, 2020

Primary Completion (Actual)

May 31, 2022

Study Completion (Actual)

May 31, 2022

Study Registration Dates

First Submitted

August 27, 2020

First Submitted That Met QC Criteria

November 11, 2020

First Posted (Actual)

November 18, 2020

Study Record Updates

Last Update Posted (Actual)

June 2, 2022

Last Update Submitted That Met QC Criteria

June 1, 2022

Last Verified

June 1, 2022

More Information

Terms related to this study

Other Study ID Numbers

  • SoCoStim

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Aging

Clinical Trials on Social Cognition Task

Subscribe